Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Vascular access outcomes and medication use: a USRDS study.

Vascular access outcomes and medication use: a USRDS study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Vascular access outcomes and medication use: a USRDS study. Abstract Text:

    alexander s yevzlinAlexander S Yevzlin,emily l conleyEmily L Conley,robert j sanchezRobert J Sanchez,henry n youngHenry N Young,bryan n beckerBryan N Becker,

    Several medications have been proposed to improve hemodialysis (HD) vascular access outcomes based on potentially favorable anticoagulant, antiplatelet, or pleiotropic properties. The purpose of this study was to evaluate the relationship between medication use and vascular access patency in a group of HD patients. We conducted a historical cohort study of the US Renal Data System Dialysis Mortality and Morbidity Wave II study to identify patients with an arteriovenous fistula (AVF), polytetrafluoroethylene (PTFE) graft, or a permanent catheter for vascular access. Cox regression analysis, adjusted for age, gender, race, history of coronary artery disease, peripheral vascular disease, or coronary artery bypass graft, was used to model the hazard ratio (HR) of permanent vascular access failure. Of the 2001 HD patients in the Wave II study, 901 (45%) were included in the analysis. PTFE graft patency was greater for males (HR, 0.73; 95% CI 0.53-1.00, p = 0.05) and for older individuals (HR, 0.99; 95% CI 0.98-1.00, p = 0.02). Treatment with antiplatelet medications, ticlopidine and dipyridamole (HR, 3.54; 95% CI 1.07-11.76; p = 0.04), or aspirin (HR, 2.49; 95% CI 1.31-4.73; p = 0.005) was associated with significantly worse AVF patency. Antiplatelet agents had a significant negative association with access patency in this cohort. In contrast to other published data, it was difficult to identify any beneficial effect of specific medications on access patency.

    Vascular access outcomes and medication use: a USRDS study. Publishing Authors By Initials

    as yevzlinAS Yevzlin,el conleyEL Conley,rj sanchezRJ Sanchez,hn youngHN Young,bn beckerBN Becker,

    For similar circulatory and respiratory physiology: cardiovascular physiology: cardiovascular physiologic phenomena: vascular patency research abstracts see: circulatory and respiratory physiology: cardiovascular physiology: cardiovascular physiologic phenomena: vascular patency research

    PUBMED ID PMID:

    MEDLINE DATE:

    Vascular access outcomes and medication use: a USRDS study. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Seminars in dialysis

    VOLUME: 19

    Page Numbers: 535-9

    Journal Abbreviation:

    ISSN: 0894-0959

    DAY: 3

    MONTH: 12

    YEAR: 2007

    Vascular access outcomes and medication use: a USRDS study. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8911629

    Vascular access outcomes and medication use: a USRDS study. Keywords Mesh Terms:

    KEYWORDS: Vascular Patency

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Vascular access outcomes and medication use: a USRDS study. Information

    Substance Name: Polytetrafluoroethylene

    Registry Number: 9002-84-0

    Grant and Affiliation Information for Vascular access outcomes and medication use: a USRDS study.

    AFFILIATION: School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53713, USA. asy@medicine.wisc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: 1K24DK616962-04

    ACRONYM: DK

    MEDLINETA: Semin Dial

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Vascular access outcomes and medication use: a USRDS study Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News